Publication | Closed Access

TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages

Agonist ReversesMedicineImmunologyMyeloid-derived Suppressor CellsColorectal CancerImmune Checkpoint InhibitorTumor SuppressorOncologyCell BiologyCancer ResearchTumor MicroenvironmentTumor Biology